34 Participants Needed

Combined Respiratory Training for ALS

LT
DM
Overseen ByDonovan Mott
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Nova Southeastern University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this interventional trial is to learn about lung volume recruitment (LVR) and expiratory muscle strength training (EMST) in a total of up to 39 patients diagnosed with ALS. The following aims will be addressed: 1. Determine the impact of combined LVR and EMST on cough strength and respiratory function in individuals with ALS. 2. Determine the impact of combined LVR and EMST on patient-reported dyspnea and bulbar impairment. 3. Describe the effect of combined LVR and EMST on patient- and caregiver reported burden and quality of life.

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. However, if you are using prescription cough assist or non-invasive volume ventilation devices, you cannot participate in the trial.

What data supports the effectiveness of the treatment Combined Respiratory Training for ALS?

Research shows that lung volume recruitment (a technique to help with breathing) can improve coughing and lung function in ALS patients. Additionally, a case study found that respiratory strength training improved breathing muscle strength and cough flow in an ALS patient over two years.12345

Is Combined Respiratory Training safe for humans?

Research on Combined Respiratory Training, including techniques like Lung Volume Recruitment and Expiratory Muscle Strength Training, has been conducted in people with ALS and shows positive effects on breathing and coughing without significant safety concerns reported.13678

How does the Combined Respiratory Training treatment for ALS differ from other treatments?

Combined Respiratory Training for ALS is unique because it combines Lung Volume Recruitment (a technique to improve lung capacity and coughing) and Expiratory Muscle Strength Training (a method to enhance breathing muscle strength), which together aim to improve respiratory function and cough effectiveness in ALS patients, unlike standard treatments that may not address these specific aspects.137910

Research Team

MT

Magalie Thomas, MBA

Principal Investigator

Nova Southeastern University

Eligibility Criteria

This trial is for people with ALS who have had symptoms for less than 2 years, can't already use respiratory training devices, and don't have a tracheostomy or need invasive breathing support. They shouldn't be in other studies that affect coughing or breathing and must not have severe lung diseases like COPD.

Inclusion Criteria

I have never undergone lung volume or expiratory muscle strength training.
My symptoms started less than 2 years ago.
My cough strength is weaker than normal for my age and gender.
See 1 more

Exclusion Criteria

I have a tracheostomy or use a ventilator to help me breathe.
I am not part of another study that could affect my cough or breathing.
I do not have severe lung problems or a history of collapsed lung.
See 3 more

Timeline

Screening/Baseline 1

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Baseline 2

Introduction of LVR and EMST training with initial training session

1 week
1 visit (in-person)

Active Training

Weekly telehealth therapy sessions including LVR and EMST training, peak cough flow assessment, and patient-reported outcomes

5 weeks
4 visits (virtual)

Final Evaluation

Final assessment procedures identical to Baseline 2

1 week
1 visit (in-person)

Follow-up

Monthly telehealth visits for peak cough flow and maximum phonation time assessments, and clinician-administered surveys

6 months
6 visits (virtual)

Treatment Details

Interventions

  • Combined Respiratory Training
Trial OverviewThe study tests if combining two types of breathing exercises (LVR+EMST) helps improve cough strength, breath control, swallowing difficulties, and overall quality of life in up to 39 patients with ALS. It also looks at the impact on caregiver burden.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Lung Volume Recruitment +Expiratory Muscle Strength TrainingExperimental Treatment1 Intervention
All enrolled participants will commence a combined lung volume recruitment and expiratory muscle strength training exercise regimen following a 5-week no-intervention lead-in period.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nova Southeastern University

Lead Sponsor

Trials
103
Recruited
12,000+

Congressionally Directed Medical Research Programs

Collaborator

Trials
59
Recruited
10,600+

Findings from Research

A 12-week respiratory strength training (RST) program significantly improved maximum expiratory pressure (MEP) in individuals with early-stage amyotrophic lateral sclerosis (ALS), with an average increase of 20.8 cm H2O, indicating enhanced breathing capacity.
The RST program was well tolerated with a 91% completion rate and no adverse events, and it showed a slower rate of bulbar decline over one year compared to sham training, suggesting potential long-term benefits for airway clearance and respiratory function.
Respiratory Strength Training in Amyotrophic Lateral Sclerosis: A Double-Blind, Randomized, Multicenter, Sham-Controlled Trial.Plowman, EK., Gray, LT., Chapin, J., et al.[2023]
In a study of 40 ALS patients, both the breath-stacking technique and mechanical insufflator-exsufflator (MI-E) showed similar rates of chest infections and hospitalization, indicating comparable safety profiles for these cough augmentation methods.
Although there were no statistically significant differences in outcomes, the breath-stacking technique is recommended as a low-cost first-line intervention for cough support in ALS patients, pending further research to confirm its efficacy compared to MI-E.
A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis.Rafiq, MK., Bradburn, M., Proctor, AR., et al.[2017]
Lung volume recruitment (LVR) significantly improved forced vital capacity (FVC) for up to 15 minutes after treatment in 29 individuals with amyotrophic lateral sclerosis (ALS), indicating a temporary enhancement in pulmonary function.
LVR also positively affected peak cough flow (PCF) during unassisted coughing at both 15 and 30 minutes post-treatment, suggesting it may help improve coughing effectiveness in ALS patients.
The effects of lung volume recruitment on coughing and pulmonary function in patients with ALS.Cleary, S., Misiaszek, JE., Kalra, S., et al.[2015]

References

Respiratory Strength Training in Amyotrophic Lateral Sclerosis: A Double-Blind, Randomized, Multicenter, Sham-Controlled Trial. [2023]
A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis. [2017]
The effects of lung volume recruitment on coughing and pulmonary function in patients with ALS. [2015]
Combined respiratory training in an individual with C9orf72 amyotrophic lateral sclerosis. [2019]
Impact of expiratory strength training in amyotrophic lateral sclerosis. [2018]
Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham-controlled trial. [2020]
POWERbreathe® Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis. [2023]
Comparison between breath stacking technique associated with expiratory muscle training and breath stacking technique in amyotrophic lateral sclerosis patients: Protocol for randomized single blind trial. [2022]
Expiratory Muscle Strength Training in patients After Total Laryngectomy; A Feasibility Pilot Study. [2022]
The Efficacy of Expiratory Muscle Training during Inspiratory Load in Healthy Adult Males: A Randomized Controlled Trial. [2023]